These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2253090)
1. Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Peng Z; Lee HB; Proud D; Naclerio R; Adkinson NF Clin Exp Allergy; 1990 Sep; 20(5):571-9. PubMed ID: 2253090 [TBL] [Abstract][Full Text] [Related]
2. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. Hedlin G; Silber G; Schieken L; Naclerio R; Proud D; Eggleston P; Adkinson NF J Allergy Clin Immunol; 1989 Sep; 84(3):390-9. PubMed ID: 2476472 [TBL] [Abstract][Full Text] [Related]
3. Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. Peng ZK; Naclerio RM; Norman PS; Adkinson NF J Allergy Clin Immunol; 1992 Feb; 89(2):519-29. PubMed ID: 1740582 [TBL] [Abstract][Full Text] [Related]
4. A double-blind study of the discontinuation of ragweed immunotherapy. Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339 [TBL] [Abstract][Full Text] [Related]
5. Dose response of IgE and IgG antibodies during ragweed immunotherapy. Creticos PS; Van Metre TE; Mardiney MR; Rosenberg GL; Norman PS; Adkinson NF J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):94-104. PubMed ID: 6607272 [TBL] [Abstract][Full Text] [Related]
6. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy. Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D; N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
9. Quantitation of IgE antibody specific for ragweed and grass allergens: binding of radiolabeled allergens by solid-phase bound IgE. Zeiss CR; Levitz D; Suszko IM J Allergy Clin Immunol; 1978 Aug; 62(2):83-90. PubMed ID: 670609 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract. Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients. Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540 [TBL] [Abstract][Full Text] [Related]
12. Isotypic and antigenic restriction of the blocking antibody response to ryegrass pollen: correlation of rye group I antigen-specific IgG1 with clinical response. Moss RB; Hsu YP; Kwasnicki JM; Sullivan MM; Reid MJ J Allergy Clin Immunol; 1987 Feb; 79(2):387-98. PubMed ID: 3819220 [TBL] [Abstract][Full Text] [Related]
13. The clinical role of specific IgE and IgG4 antibodies in patients having immunotherapy for seasonal allergic rhinitis. Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Sakamoto H Clin Otolaryngol Allied Sci; 1998 Apr; 23(2):128-35. PubMed ID: 9597282 [TBL] [Abstract][Full Text] [Related]
14. Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects. Tulic MK; Christodoulopoulos P; Fiset PO; Vaillancourt P; Lavigne F; Marshall JD; Van Nest G; Eiden JJ; Hamid Q Allergol Int; 2009 Dec; 58(4):565-72. PubMed ID: 19776676 [TBL] [Abstract][Full Text] [Related]
15. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever. Van Metre TE; Adkinson NF; Amodio FJ; Kagey-Sobotka A; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL J Allergy Clin Immunol; 1982 Feb; 69(2):181-93. PubMed ID: 7056949 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Hedlin G; Silber G; Naclerio R; Proud D; Lamas AM; Eggleston P; Adkinson NF Clin Exp Allergy; 1990 Sep; 20(5):491-500. PubMed ID: 2253080 [TBL] [Abstract][Full Text] [Related]
17. Local intranasal immunotherapy for ragweed allergic rhinitis. II. Immunologic response. Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE J Allergy Clin Immunol; 1981 Jul; 68(1):41-5. PubMed ID: 6972401 [TBL] [Abstract][Full Text] [Related]
18. Short ragweeds is highly cross-reactive with other ragweeds. Christensen LH; Ipsen H; Nolte H; Maloney J; Nelson HS; Weber R; Lund K Ann Allergy Asthma Immunol; 2015 Dec; 115(6):490-495.e1. PubMed ID: 26507708 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical and genetic studies of Amb.t. V (Ra5G), an Ra5 homologue from giant ragweed pollen. Roebber M; Klapper DG; Goodfriend L; Bias WB; Hsu SH; Marsh DG J Immunol; 1985 May; 134(5):3062-9. PubMed ID: 3856613 [TBL] [Abstract][Full Text] [Related]
20. Multiple Amb a I allergens demonstrate specific reactivity with IgE and T cells from ragweed-allergic patients. Bond JF; Garman RD; Keating KM; Briner TJ; Rafnar T; Klapper DG; Rogers BL J Immunol; 1991 May; 146(10):3380-5. PubMed ID: 1709193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]